CMA
NEO icon

Cedar Mountain Advisors’s NeoGenomics NEO Stock Holding History

Cedar Mountain Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23
Closed -$171 – 1205
2026
Q1 		$171 Hold
23
– – ﹤0.01% 1103
2025
Q4 		$270 Buy
+23
New +$248 ﹤0.01% 659

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Cedar Mountain Advisors's NEO Position: Q2 2026 in Review

Cedar Mountain Advisors sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 23 shares — an estimated $171 sold.

Cedar Mountain Advisors first reported a position in NEO in Q4 2025 and held it in 2 quarters. The position peaked at $270 in Q4 2025. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Cedar Mountain Advisors reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Cedar Mountain Advisors sold 23 NeoGenomics shares in Q2 2026, an estimated $171.
  • Cedar Mountain Advisors first reported a position in NeoGenomics in Q4 2025 and held it in 2 quarters.
  • Cedar Mountain Advisors's NeoGenomics position peaked at $270 in Q4 2025.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.